CRIS Current Research Information System

MONALDI, CECILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.736
NA - Nord America 879
EU - Europa 682
AF - Africa 100
SA - Sud America 70
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 858
VN - Vietnam 761
SG - Singapore 398
CN - Cina 274
IT - Italia 233
HK - Hong Kong 112
DE - Germania 84
GB - Regno Unito 67
NL - Olanda 67
SE - Svezia 58
BR - Brasile 49
FR - Francia 40
IN - India 40
IE - Irlanda 38
KR - Corea 34
TG - Togo 34
CI - Costa d'Avorio 25
RU - Federazione Russa 21
FI - Finlandia 18
ZA - Sudafrica 16
CA - Canada 14
JP - Giappone 14
JO - Giordania 13
NG - Nigeria 13
IQ - Iraq 12
TW - Taiwan 12
IR - Iran 11
PL - Polonia 11
TH - Thailandia 10
AT - Austria 8
BD - Bangladesh 6
EC - Ecuador 6
ES - Italia 6
PH - Filippine 6
UA - Ucraina 6
AR - Argentina 5
CH - Svizzera 5
ID - Indonesia 5
MX - Messico 5
SA - Arabia Saudita 5
SC - Seychelles 5
BG - Bulgaria 4
EE - Estonia 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PK - Pakistan 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
PS - Palestinian Territory 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 3.470
Salva come PNG Salva come JPEG
Città #
Singapore 309
Ho Chi Minh City 248
Hanoi 187
Chandler 114
Hong Kong 102
Ashburn 100
San Jose 63
Hefei 61
Bologna 54
Southend 50
Dublin 38
Lomé 34
Fairfield 33
Beijing 32
Santa Clara 29
Seoul 29
Abidjan 25
Princeton 24
Haiphong 22
Da Nang 20
Ha Long 20
Redmond 20
Boardman 19
Frankfurt am Main 19
Milan 19
Wilmington 19
Houston 17
Biên Hòa 16
Lauterbourg 15
Woodbridge 14
Los Angeles 13
Redondo Beach 13
Seattle 13
Thái Nguyên 13
Abeokuta 12
Tokyo 12
Berlin 11
Johannesburg 11
Cambridge 10
Council Bluffs 10
New York 10
Rome 10
Amman 9
Tehran 9
Turin 9
Hải Dương 8
Montreal 8
Nuremberg 8
Shanghai 8
Vũng Tàu 8
Bengaluru 7
Bắc Ninh 7
Guangzhou 7
Lappeenranta 7
Munich 7
Quận Bình Thạnh 7
Warsaw 7
Zhengzhou 7
Điện Bàn 7
Buffalo 6
Dallas 6
Florence 6
Helsinki 6
London 6
Ninh Bình 6
San Diego 6
Tianjin 6
Vinh 6
Ann Arbor 5
Atlanta 5
Bangkok 5
Bern 5
Boydton 5
Brescia 5
Bến Tre 5
Chicago 5
Falkenstein 5
Huế 5
Nha Trang 5
Quận Hai 5
Quận Phú Nhuận 5
Quận Sáu 5
Shenyang 5
São Paulo 5
Thái Bình 5
Turku 5
Baghdad 4
Boston 4
Can Tho 4
Changsha 4
Dehradun 4
Des Moines 4
Lang Son 4
Nanjing 4
Phủ Lý 4
Quảng Ngãi 4
Quận Năm 4
Sofia 4
Thu Dau Mot 4
Westminster 4
Totale 2.220
Salva come PNG Salva come JPEG
Nome #
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 656
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 275
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 226
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 171
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells 169
Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells 163
The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities 163
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 159
Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy 158
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 151
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 151
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia 144
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 144
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights 138
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort? 132
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis 119
Systemic mastocytosis: Molecular landscape and implications for treatment 119
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia 108
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors 94
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia 62
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability 28
Totale 3.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 3 8 13
2021/2022200 4 2 6 4 22 13 2 21 14 15 57 40
2022/2023426 44 73 17 34 44 24 24 17 78 15 44 12
2023/2024144 2 27 14 22 13 13 7 19 3 10 11 3
2024/2025688 24 122 63 51 39 24 79 33 20 70 66 97
2025/20261.869 201 569 109 139 152 60 139 46 370 84 0 0
Totale 3.530